If you need more lookups,
subscriptions start at $34 USD/month.
Kyle Kuvalanka Location
Boston, MA, US
Kyle Kuvalanka Work
2025 -now Chief Financial Officer @
2023 -2025 Chief Financial Officer and Chief Business Officer @
2023 -2023 Corporate strategy, business development and finance consultant to biopharmaceutical companies @ Self-employed
2020 -2023 Chief Financial and Operating Officer @
2018 -2023 Consultant @
2017 -2018 Corporate Strategy, Business Development and Financing Consultant @
2015 -2017 Chief Operating Officer @
2013 -2015 Chief Business Officer @
2002 -2013 Vice President, Corporate Strategy and Development @ Millennium Pharmaceuticals: The Takeda Oncology Company
1999 -1999 Summer Intern @ Pfizer
now Consultant @ TQM Group / Spire
Kyle Kuvalanka Education
The Wharton School of Business, University of Pennsylvania
MBA (Strategy, Finance)
1998-2000
Wesleyan University
BA (College of Social Studies)
1986-1990
Kyle Kuvalanka Skills
Sales
Research
Strategic Planning
PowerPoint
Customer Service
Microsoft Office
Investor Relations
Fellow
Strategic Partnerships
Drug Discovery
Kyle Kuvalanka Summary
Kyle Kuvalanka, based in Boston, MA, US, is currently a Chief Financial Officer at Aktis Oncology. Kyle Kuvalanka brings experience from previous roles at ROME Therapeutics, Self-employed, Goldfinch Bio and Third Rock Ventures. Kyle Kuvalanka holds a 1998 - 2000 MBA in Strategy, Finance @ The Wharton School of Business, University of Pennsylvania. With a robust skill set that includes Sales, Research, Strategic Planning, PowerPoint, Customer Service and more. Kyle Kuvalanka has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Kyle Kuvalanka?
Find contact details for 700 million professionals.